2010
DOI: 10.1128/mcb.00379-10
|View full text |Cite
|
Sign up to set email alerts
|

MeCP2 Binds Cooperatively to Its Substrate and Competes with Histone H1 for Chromatin Binding Sites

Abstract: Sporadic mutations in the hMeCP2 gene, coding for a protein that preferentially binds symmetrically methylated CpGs, result in the severe neurological disorder Rett syndrome (RTT). In the present work, employing a wide range of experimental approaches, we shed new light on the many levels of MeCP2 interaction with DNA and chromatin. We show that strong methylation-independent as well as methylation-dependent binding by MeCP2 is influenced by DNA length. Although MeCP2 is strictly monomeric in solution, its bin… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

13
116
0
1

Year Published

2010
2010
2023
2023

Publication Types

Select...
7
2
1

Relationship

2
8

Authors

Journals

citations
Cited by 181 publications
(136 citation statements)
references
References 70 publications
13
116
0
1
Order By: Relevance
“…In addition to the gene-specific binding, chromatin-immunoprecipitation (ChIP) studies revealed that MeCP2 binds widely throughout the genome (Yasui et al 2007;Skene et al 2010) and is as abundant as one molecule for every two nucleosomes (Skene et al 2010). The findings that MeCP2 and H1 compete for DNA binding sites support the hypothesis that MeCP2 might act as an alternative linker histone (Ghosh et al 2010;Skene et al 2010). However, how such competition causes the specific Rett and MeCP2 duplication phenotypes and the root of the very specific opposing gene expression changes are not clear at this time.…”
Section: Pathophysiologysupporting
confidence: 60%
“…In addition to the gene-specific binding, chromatin-immunoprecipitation (ChIP) studies revealed that MeCP2 binds widely throughout the genome (Yasui et al 2007;Skene et al 2010) and is as abundant as one molecule for every two nucleosomes (Skene et al 2010). The findings that MeCP2 and H1 compete for DNA binding sites support the hypothesis that MeCP2 might act as an alternative linker histone (Ghosh et al 2010;Skene et al 2010). However, how such competition causes the specific Rett and MeCP2 duplication phenotypes and the root of the very specific opposing gene expression changes are not clear at this time.…”
Section: Pathophysiologysupporting
confidence: 60%
“…Samples were diluted as needed, applied to glow-discharged carbon-coated grids, stained with 0.1% aqueous uranyl acetate, and washed extensively with water. Grids were examined in a Tecnai 12 TEM LaB6 filament operated at 100 kV in the tilted darkfield mode, and digital images were recorded using a TVIPS 2024 ϫ 2024 CCD camera (31).…”
Section: Methodsmentioning
confidence: 99%
“…MeCP2 minimally binds 11 bp of DNA (9). Under these conditions, unmethylated and methylated DNA binding sites were present in molar excess over MeCP2, and DNA concentrations were always above the K d (5) so that H/DX was being measured under saturated binding conditions and dual population (i.e. bound and unbound to DNA) affects were avoided.…”
Section: Methodsmentioning
confidence: 99%